We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

174 hedge funds and large institutions have $1.41B invested in Dr. Reddy's Laboratories in 2015 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 64 increasing their positions, 58 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

53% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 15

10% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 58

9% more capital invested

Capital invested by funds: $1.3B → $1.41B (+$111M)

4% more funds holding

Funds holding: 168174 (+6)

3.37% less ownership

Funds ownership: 75.89%72.52% (-3.4%)

Holders
174
Holders Change
+6
Holders Change %
+3.57%
% of All Funds
4.64%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
23
Increased
64
Reduced
58
Closed
15
Calls
$58K
Puts
Net Calls
+$58K
Net Calls Change
+$58K
Name Holding Trade Value Shares
Change
Change in
Stake
Mitsubishi UFJ Trust & Banking
51
Mitsubishi UFJ Trust & Banking
Japan
$3.62M -$1.72M -162,560 -34%
T. Rowe Price Associates
52
T. Rowe Price Associates
Maryland
$3.62M -$5.47M -516,135 -62%
BlackRock
53
BlackRock
New York
$3.23M -$945K -89,085 -24%
Neuberger Berman Group
54
Neuberger Berman Group
New York
$3.22M +$667K +62,875 +29%
BNP Paribas Asset Management
55
BNP Paribas Asset Management
France
$3.03M
DCM
56
Driehaus Capital Management
Illinois
$2.97M +$2.76M +259,775 New
GH
57
GAM Holding
Switzerland
$2.92M -$225K -21,250 -8%
PP
58
PDT Partners
New York
$2.87M +$2.66M +251,065 New
T
59
Tahithromos
New York
$2.85M
NMC
60
Nine Masts Capital
Hong Kong
$2.83M +$2.62M +247,445 New
MAA
61
Managed Account Advisors
New Jersey
$2.71M +$500K +47,090 +25%
Morgan Stanley
62
Morgan Stanley
New York
$2.68M -$19.3M -1,823,230 -89%
Bank of New York Mellon
63
Bank of New York Mellon
New York
$2.68M -$504K -47,515 -17%
Fidelity Investments
64
Fidelity Investments
Massachusetts
$2.63M -$260K -24,500 -10%
DnB Asset Management
65
DnB Asset Management
Norway
$2.54M -$40.6K -3,825 -2%
HSBC Holdings
66
HSBC Holdings
United Kingdom
$2.34M +$410K +38,665 +23%
Wellington Management Group
67
Wellington Management Group
Massachusetts
$2.33M -$8.77M -827,005 -80%
CAM
68
ClariVest Asset Management
California
$2.31M -$1.08M -102,000 -34%
AAM
69
Advisors Asset Management
Colorado
$2.29M +$466K +43,905 +28%
Wells Fargo
70
Wells Fargo
California
$2.15M +$902 +85 +0%
ACI
71
AMP Capital Investors
Australia
$2.09M -$549K -51,780 -22%
ACM
72
Ativo Capital Management
Illinois
$2.06M +$117K +11,070 +7%
PSCM
73
Prince Street Capital Management
New York
$2.02M +$1.88M +177,000 New
BIT
74
BlackRock Institutional Trust
California
$1.99M -$7.42M -699,725 -80%
Natixis Advisors
75
Natixis Advisors
Massachusetts
$1.87M +$206K +19,410 +13%

RDY Hedge Fund Activity: Q1 2015 in Review

174 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2015, worth a combined $1.41B — up 8.5% from $1.3B a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new RDY positions and 15 closed out — a net gain of 8 holders — while 64 added to existing stakes and 58 trimmed.

The largest buyer was Fisher Asset Management, adding an estimated $56.4M. The largest seller was Fidelity International, cutting an estimated $34.8M.

  • 174 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2015, up from 168 in Q4 2014.
  • Funds reported $1.41B of Dr. Reddy's Laboratories stock for Q1 2015, up 8.5% quarter-over-quarter.
  • 23 funds opened new Dr. Reddy's Laboratories positions in Q1 2015 and 15 closed out, a net change of +8 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q1 2015 was Fisher Asset Management, an estimated $56.4M added.
  • The largest Dr. Reddy's Laboratories seller in Q1 2015 was Fidelity International, an estimated $34.8M sold.

Based on aggregated 13F filings for Q1 2015.